Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer.
about
Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinasesDiagnostic imaging advances in murine models of colitis.Insidious changes in stromal matrix fuel cancer progressionSelective glucocorticoid receptor-activating adjuvant therapy in cancer treatmentsDexamethasone reduces sensitivity to cisplatin by blunting p53-dependent cellular senescence in non-small cell lung cancerAnti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo model.Genomics and proteomics approaches to the study of cancer-stroma interactions.Metalloproteinase binding proteins: WO2009097397.Dual-wavelength imaging of tumor progression by activatable and targeting near-infrared fluorescent probes in a bioluminescent breast cancer model.Variability in melanoma metalloproteinase expression profilingRETRACTED: The effects of dexamethasone on the proliferation and apoptosis of human ovarian cancer cells induced by paclitaxel.Induction of ΔNp63 by the newly identified keratinocyte-specific transforming growth factor β Signaling Pathway with Smad2 and IκB Kinase α in squamous cell carcinoma.Impact of stress on cancer metastasisLaminin-332-rich tumor microenvironment for tumor invasion in the interface zone of breast cancer.Stromal LRP1 in lung adenocarcinoma predicts clinical outcome.System-wide analysis reveals a complex network of tumor-fibroblast interactions involved in tumorigenicityThe molecular pathogenesis of head and neck cancer.Probing the biophysical properties of primary breast tumor-derived fibroblasts.Computerized detection and analysis of cancer chemotherapy-induced emesis in a small animal model, musk shrew.Membrane type 1 matrix metalloproteinase (MT1-MMP) ubiquitination at Lys581 increases cellular invasion through type I collagen.Genetic ablation of Cav1 differentially affects melanoma tumor growth and metastasis in mice: role of Cav1 in Shh heterotypic signaling and transendothelial migration.Chronic restraint stress attenuates p53 function and promotes tumorigenesis.Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapyGlucocorticoid compounds modify smoothened localization and hedgehog pathway activityTumour endoproteases: the cutting edge of cancer drug delivery?Bilayer Membrane Modulation of Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Structure and Proteolytic Activity.Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer.High glucose-induced resistance to 5-fluorouracil in pancreatic cancer cells alleviated by 2-deoxy-D-glucose.Tissue-specific actions of glucocorticoids on apoptosis: a double-edged sword.Genetic regulation and potentially therapeutic application of cancer-associated fibroblasts in oral cancer.Matrix metalloproteinases: the gene expression signatures of head and neck cancer progression.High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer.Interactions of human MSC with head and neck squamous cell carcinoma cell line PCI-13 reduce markers of epithelia-mesenchymal transition.SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma.Brain derived neutrophic factor (BDNF) coordinates lympho-vascular metastasis through a fibroblast-governed paracrine axis in the tumor microenvironment.Senescent cancer-associated fibroblasts secrete active MMP-2 that promotes keratinocyte dis-cohesion and invasion.MT-LOOP-dependent localization of membrane type I matrix metalloproteinase (MT1-MMP) to the cell adhesion complexes promotes cancer cell invasion.Cancer seeding contributes to intestinal anastomotic dehiscence.Arsenic enhances matrix metalloproteinase-14 expression in fibroblasts.
P2860
Q24617675-AE66E882-7269-4100-8117-D5E4350E61A2Q26774583-5469BA33-45CF-42FC-9458-4E41827ABA01Q26851261-FB5FCC22-1F98-45F6-9EA7-87164FDE2045Q28078896-5A3EE29A-CBB5-4A87-B0FE-CF8CBA90D5B5Q28484432-92B90E16-32D4-4AA5-B7B5-10E81DD206DDQ33737169-334FAE94-B2C8-4702-987E-9398A0BD05CAQ33895270-F0117B9A-93A7-4825-BFDB-3A6A5595876BQ34030049-37007586-4762-40C6-8CC0-23918E59825FQ34163763-DA163B93-3CB3-4833-B739-6DDF8969592BQ34296399-8CC93F09-C2F3-4BB2-B14D-E42F865DAFFDQ34355401-958BF3B9-3B10-4815-98F1-C81CC5985539Q34411687-F3746A15-4D4E-48A7-BA0B-F80F49CE4C85Q34569251-825418D2-920A-455E-903F-B25F8561959FQ34756075-7D219FFF-9DE8-4632-961F-ABB0DD5F5F1AQ34810329-A78E5955-F959-490B-8A4B-180AC1B7ED2AQ34998315-FD5EFB9C-59DB-42A7-981D-91461048A85FQ35111736-692348C8-B539-4F0F-A522-7119B5FAD9ECQ35322761-95207633-5DD2-4B82-8160-C68369F950B9Q35871181-9FA0C7F3-9BF9-4EAD-AA3A-F585CA910AE4Q35879654-FE098A81-0020-4AF1-84D0-C84061FC2F50Q35928528-B0E6382B-EE5F-4B81-A3A1-C43965548353Q35935831-8801FA9F-BBFA-4FCA-B262-3E8756D19AA9Q36653033-D53CD6B9-C511-4465-BA30-B37E9D636E7CQ37049203-FDC4D9FF-EEC7-4A2A-891E-3536704E62AEQ37060284-A3FBF199-BB8C-44A1-94B9-B89515A6083CQ37089575-55C6FEA6-3C13-408E-A3AE-118FF09A0584Q37484367-13A591D0-E9EA-4F93-B90E-4FA6F2D5586BQ37567719-8B20B2A8-CCE1-4026-91C5-57F103C45653Q37679245-75DB9C3A-1EF2-44F3-8643-4C85DA0E148FQ38115617-084846BC-A138-4999-B595-524EE5E18986Q38188373-018985EA-8BD5-41DD-A5D4-85DA03C7709AQ38812945-0F2E08D0-88E3-4257-B7E8-1DA663FCF1AFQ38945001-412222A5-C14D-491C-B242-B5AE33199633Q39671092-870EA622-5B89-4D02-91AB-7B7F6D88CE25Q39733328-5D187051-4893-43EC-86A7-A0E1FC8346F0Q41683662-796571BB-8422-4724-84C9-009F3F4ED53EQ41844791-7F3E3837-FA54-44C8-B86D-B2DFC9141CF2Q42841372-3C239BA5-08DC-4244-811F-04F64020B447Q42980208-F22A7AC1-0754-44E0-9ED7-445FFFAE95B4Q44482111-BF56C6A6-0502-4237-BA2A-21E45FB75E59
P2860
Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Corticosteroid co-treatment in ...... ll lines of pancreatic cancer.
@ast
Corticosteroid co-treatment in ...... ll lines of pancreatic cancer.
@en
type
label
Corticosteroid co-treatment in ...... ll lines of pancreatic cancer.
@ast
Corticosteroid co-treatment in ...... ll lines of pancreatic cancer.
@en
prefLabel
Corticosteroid co-treatment in ...... ll lines of pancreatic cancer.
@ast
Corticosteroid co-treatment in ...... ll lines of pancreatic cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Corticosteroid co-treatment in ...... ll lines of pancreatic cancer.
@en
P2093
Andrew C B Cato
Armin Kolb
Chengwen Zhang
Ingrid Herr
Jürgen Mattern
Lutz Edler
Peter Büchler
Werner Rittgen
P2860
P2888
P356
10.1186/1471-2407-6-52
P407
P577
2006-03-15T00:00:00Z
P5875
P6179
1043582243